Loading stock data…
Loading stock data…
US$12.76
Get one email when ZVRA crosses your level. Checked every 15 minutes during market hours.
▼ -0.20 (-1.54%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
46.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.28
Bearish momentumMACD below its signal line (0.51).
50-day average
12.20
Price aboveShort-term trend reference.
200-day average
10.07
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on treatments for rare diseases. The company concentrates on rare neurological and sleep-related conditions, including certain urea cycle disorders, Niemann-Pick disease type C, and idiopathic hypersomnia. Zevra Therapeutics develops and commercializes therapies aimed at patient populations with limited or no existing treatment options, emphasizing data-driven development and close alignment with patient needs. In a…
www.zevra.com5 strong buy · 9 buy · 1 hold · 0 sell · 0 strong sell (15 analysts, 2026-07-01)
5 strong buy · 9 buy · 1 hold · 0 sell · 0 strong sell (15 analysts, 2026-06-01)
5 strong buy · 9 buy · 1 hold · 0 sell · 0 strong sell (15 analysts, 2026-05-01)
5 strong buy · 9 buy · 1 hold · 0 sell · 0 strong sell (15 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-06 | 0.08 | 0.18 | ✓ Beat |
| 2026-03-19 | 0.16 | 0.17 | ✓ Beat |
| 2026-03-09 | 0.05 | 0.19 | ✓ Beat |
| 2025-11-05 | -0.02 | -0.01 | ✓ Beat |
| 2025-08-12 | 1.38 | -0.06 | ✗ Miss |
| 2025-05-13 | -0.18 | -0.06 | ✓ Beat |
| 2025-03-11 | -0.4 | -0.69 | ✗ Miss |
Companies in the same industry, via Finnhub